The new vials feature added external low-friction coating developed by Corning.
SGD Pharma’s vial-converting expertise is combined with Corning’s proprietary glass-coating technology to improve pharmaceutical filling-line productivity and speed the global delivery of injectable treatments.
Defective vials can force production lines to stop and more critically may result in recalls and increased manufacturing costs.
SGD said its Velocity Vial reduce the frictional resistance created by glass-to-glass and glass-to-metal contact, helping pharmaceutical filing lines to prevent potential disruptions to the flow of vials, which can include tip-overs, jams and glass breakages.
Pharma filling companies will see a reduction in glass particulates, according to the firm.
